期刊文献+

自身免疫性肝炎患者T淋巴细胞活化指标检测价值探讨 被引量:5

Detection value of T lymphocyte activation index in patients with autoimmune hepatitis
原文传递
导出
摘要 目的探讨自身免疫性肝炎(AIH)患者外周血T淋巴细胞表达活化指标HLA-DR、CD25、CD38在AIH发生发展中的机制及临床检测价值。方法应用流式细胞术检测73例AIH组发病期患者、61例AIH组缓解期患者和35例健康对照组外周血T淋巴细胞免疫活化指标(HLA-DR、CD25、CD38),对AIH组发病期、AIH组缓解期与健康对照组的免疫活化指标表达百分率进行比较。结果 AIH组发病期HLA-DR^+、CD3^+HLA-DR^+、CD8^+HLA-DR^+、CD25^+、CD38^+、CD8^+CD38^+表达百分率均高于健康对照组;各组间百分率均数的比较,差异均有统计学意义(P<0.05)。AIH组缓解期HLA-DR^+、CD3^+HLA-DR^+、CD8^+HLA-DR^+、CD25^+、CD38^+、CD8^+CD38^+表达百分率低于发病期,差异均有统计学意义(P<0.05)。结论 T淋巴细胞活化指标HLA-DR、CD25、CD38在AIH发病期表达增加,缓解期表达降低;CD4^+CD25^+在AIH发病期表达降低,缓解期表达增加。 Objective To investigate the mechanism and clinical value of the expression of HLA - DR, CD25, CD38 in the development and progression of AIH in peripheral blood T lymphocytes in patients with autoimInune hepatitis (AIH). Methods Flow cytometry (FCM) was used to detect the activation markers (HLA- DR, CD25, CD38)of T lymphocytes in peripheral blood of patients in the group of 73 cases of AIH patients in incidence, 61 cases of AIH patients in remission and 35 healthy controls. The expression of the immune activation index in the AIH group, the remission period of the AIH group and the healthy control group were compared. Results The expression of CD3^+ HLA - DR^+ , CD8^+ HLA - DR^+ , HLA - DR^+, CD25^+ , CD38^+ , CD8^+ CD38^+ is higher in AIH incidence group than those in the healthy control, and the difference was statistically significant (P 〈0.05). The expression of HLA - DR^+ , CD3^+ HLA - DR^+ , CD8^+ HLA - DR^+ , CD25^+ , CD38^+ , CD8^+ CD38^+ in the AIH remission group is lower than the AIH incidence group and the difference was statistically significant ( P 〈 0.05 ). Conclusion T lymphocyte activation markers HLA - DR, CD25, CD38 increased the incidence period of AIH, while they reduced in remission period ; CD4^+CD25^+ reduced the incidence period of AIH, while they increased in remission period.
作者 陈芳琴 陶叶海 CHEN Fang - qin TAO Ye - hai(Tashan Community Health Service Center of Yuecheng District, Shaoxing, Zhejiang 321000, China)
出处 《中国卫生检验杂志》 CAS 2017年第9期1281-1283,共3页 Chinese Journal of Health Laboratory Technology
关键词 肝炎 自身免疫性 T淋巴细胞 活化 Hepatitis Autoimmune T lymphocyte Activation
  • 相关文献

参考文献7

二级参考文献45

  • 1张占卿,张志勇.慢性乙型肝炎的疾病状态评估[J].中华临床医师杂志(电子版),2012,6(20):6-8. 被引量:8
  • 2Sadallahg S, Giostra E, Mentha G, et al. Increased levels of soluble complement receptor 1 in serum patients with liver diseases[J]. Hepatology, 1996,24(1):118- 112.
  • 3Xavier D,Steophane O,Marcelle T,et al. Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): vesiculation and/or proteolysis[ J].Immunopharmacology, 1997,38(1): 129 - 140.
  • 4Miyaike J,Iwasaki Y,Takahashi A,et al. Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases. Gut,2002,51(4) :591 - 596.
  • 5Kanto T, Hayashi N, takehara T, et al. Low expression of erythrocytes complement receptor type 1 in chronic hepatitis C patients. J Med Virol, 1996,50(2) :126 - 134.
  • 6Tausk F, McCutchan J, Spechko P,et al. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest, 1986 ,78(4),977 - 979.
  • 7唐峰,胡锡琪.自身免疫性肝病的组织病理学.见:邱德凯,马雄主编.自身免疫性肝病基础与临床.上海:上海科学技术出版社,2006.64-71.
  • 8Krawitt EL.Autoimmune hepatitis.N Engl J Med,2006,354 (1):54-66.
  • 9Czaja AJ,Marms MP,McFarlane IG,et al.Autoimmune hepatitis:the investigational and clinical challenges,Hepatology,2000,31 (5):1194-1200.
  • 10Czaja A J,Freese DK; American Association for the Study of Liver Disease.Diagnosis and treatment of autoimmune hepatitis.Hepatology,2002,36 (2):479-497.

共引文献167

同被引文献34

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部